"Designing Growth Strategies is in our DNA"

Degenerative Disc Disease Treatment Market Size, Share & COVID-19 Impact Analysis, By Type {Conventional Drugs (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Opioids, and Others), Novel Therapies (Cell Therapy, Platelet Rich Plasma (PRP), and Others)}, and Regional Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI107102

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence: Chronic Lower Back Pain, Degenerative Disc Diseases, Key Countries/ Region, 2020/2021
    2. Pipeline Analysis, Key Players
    3. New Product Launches, by Key Players
    4. Key Industry Developments - Mergers & Acquisitions
    5. Impact of COVID-19 on the Market
  5. Global Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others
    2. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others
    2. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others
    2. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others
    2. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of World Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others (transforming growth factor beta (TGFβ) receptor antagonist, etc.)
  10. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Pfizer Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Novartis AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Eli Lilly and Company
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Ferring B.V.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. FibroGenesis
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. DiscGenics, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. SpineBioPharma
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  Global Degenerative Disc Disease Treatment Market Revenue Breakdown (USD billion, %) by Region, 2021 & 2029

Figure 2:  Global Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021 & 2029

Figure 3:  Global Degenerative Disc Disease Treatment Market Value Share (%), By Region, 2021 & 2029

Figure 4:  North America Degenerative Disc Disease Treatment Market Value (USD billion), by Type, 2021 & 2029

Figure 5:  North America Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021

Figure 6:  North America Degenerative Disc Disease Treatment Market Value (USD billion), By Country, 2021 & 2029

Figure 7:  North America Degenerative Disc Disease Treatment Market Value Share (%), By Country, 2021

Figure 8:  Europe Degenerative Disc Disease Treatment Market Value (USD billion), by Type, 2021 & 2029

Figure 9:  Europe Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021

Figure 10:  Europe Degenerative Disc Disease Treatment Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 11:  Europe Degenerative Disc Disease Treatment Market Value Share (%), By Country/ Sub-region, 2021

Figure 12:  Asia Pacific Degenerative Disc Disease Treatment Market Value (USD billion), by Type, 2021 & 2029

Figure 13:  Asia Pacific Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021

Figure 14:  Asia Pacific Degenerative Disc Disease Treatment Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 15:  Asia Pacific Degenerative Disc Disease Treatment Market Value Share (%), By Country/ Sub-region, 2021

Figure 16:  Rest of the World Degenerative Disc Disease Treatment Market Value (USD billion), by Type, 2021 & 2029

Figure 17:  Rest of the World Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021

Figure 18:  Global Degenerative Disc Disease Treatment Market Share (%), By Company, 2021

Table 1:  Global Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 2:  Global Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 3:  Global Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Table 4:  Global Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Region, 2018-2029

Table 5:  North America Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 6:  North America Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 7:  North America Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Table 8:  North America Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, By Country, 2018-2029

Table 9:  Europe Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 10:  Europe Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 11:  Europe Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Table 12:  Europe Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 13:  Asia Pacific Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 14:  Asia Pacific Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 15:  Asia Pacific Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Table 16:  Asia Pacific Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 17:  Rest of the World Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 18:  Rest of the World Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 19:  Rest of the World Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Booklet
  • Jan, 2023
  • 2021
  • 2018-2020
  • 102

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X